The placebo effect has long been dismissed as purely psychological, regarded as a mental trick with no real biological basis.

Overlooked plant compounds may quietly hold new clues for treating some of the most challenging forms of pain.

NEW IBS research highlights persistent pain treatment gaps and points to peripheral nerve targets for future, safer therapies ...

A major advancement in neurological care has arrived with the launch of the world’s first Lasmiditan dispersible tablets. Designed for the acute treatment of migraine, this new formulation addresses a ...

Encore data to be presented demonstrating that cebranopadol displays significant and sustained pain reduction with a distinguished safety profile following abdominoplasty and bunionectomy - ...

Nerve growth factor (NGF) has been shown to be upregulated in joints affected by osteoarthritis, many cell types in the joint express NGF receptors, and an important NGF effect is to increase pain ...

This Boston-based biotech innovator in CNS disorders just reported significant insider selling amid a year of standout stock ...

This article examines emerging non-opioid strategies for chronic pain, from targeted ion-channel drugs and anti-inflammatory ...

PALSONIFY is the first once-daily, oral therapy approved to treat acromegaly in the European UnionApproval based on strength of data from two ...

How does the placebo effect work? A new study identifies the vlPAG brain region and endogenous opioid signaling as the keys to expectancy-driven pain relief.

When it’s time to cook a lobster, the crustaceans are infamously boiled alive. While one can safely assume that such an end ...

A Chinese research team has developed a new molecule that provides strong pain relief with far fewer side effects than traditional cannabis-based medicines, which are widely used for pain and mood ...